Patents by Inventor Anouk Fortin

Anouk Fortin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8088893
    Abstract: This invention provides HIF-3? nucleic acid and protein sequences. Also provided are methods for using HIF-3? nucleic acids, proteins, fragments, antibodies, probes, and cells, to characterize HIF-3?, modulate HIF-3? cellular levels, induce angiogenesis, improve muscular function, and treat coronary and cardiac diseases in mammals.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: January 3, 2012
    Assignee: Angiogene Inc.
    Inventors: Louis-Georges Guy, Anouk Fortin
  • Patent number: 7608698
    Abstract: This invention provides HIF-3? nucleic acid and sequences. Also provided are methods for using HIF-3? nucleic acids, proteins, fragments, antibodies, probes, and cells, to characterize HIF-3?, modulate HIF-3? cellular levels, induce angiogenesis, improve muscular function, and treat coronary and cardiac diseases in mammals.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: October 27, 2009
    Assignee: Angiogene Inc.
    Inventors: Louis-Georges Guy, Anouk Fortin
  • Publication number: 20090246180
    Abstract: This invention provides HIF-3? nucleic acid and sequences. Also provided are methods for using HIF-3? nucleic acids, proteins, fragments, antibodies, probes, and cells, to characterize HIF-3?, modulate HIF-3? cellular levels, induce angiogenesis, improve muscular function, and treat coronary and cardiac diseases in mammals.
    Type: Application
    Filed: March 10, 2009
    Publication date: October 1, 2009
    Inventors: Louis-Georges Guy, Anouk Fortin
  • Patent number: 7541183
    Abstract: Compositions and methods for modulating proliferation and/or lineage commitment of stem cells by modulating the Wnt signalling pathways. Modulators of the Wnt signalling pathways and screening methods to identify modulators are also provided. The methods of the invention may be conducted in vitro or in vivo to induce or inhibit stem cell proliferation and/or lineage commitment, and are particularly useful for in vivo stimulation of proliferation and/or lineage commitment of resident stem cells in a tissue.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: June 2, 2009
    Assignee: Ottawa Health Research Institute
    Inventors: Michael Rudnicki, Patrick Seale, Anna Polesskaya, Anouk Fortin
  • Publication number: 20060171931
    Abstract: Compositions and methods for modulating proliferation and/or lineage commitment of stem cells by modulating the Wnt signalling pathways. Modulators of the Wnt signalling pathways and screening methods to identify modulators are also provided. The methods of the invention may be conducted in vitro or in vivo to induce or inhibit stem cell proliferation and/or lineage commitment, and are particularly useful for in vivo stimulation of proliferation and/or lineage commitment of resident stem cells in a tissue.
    Type: Application
    Filed: December 22, 2005
    Publication date: August 3, 2006
    Inventors: Michael Rudnicki, Patrick Seale, Anna Polesskaya, Anouk Fortin